Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection.

Dropulic LK, Oestreich MC, Pietz HL, Laing KJ, Hunsberger S, Lumbard K, Garabedian D, Turk SP, Chen A, Hornung RL, Seshadri C, Smith MT, Hosken NA, Phogat S, Chang LJ, Koelle DM, Wang K, Cohen JI.

J Infect Dis. 2019 Aug 9;220(6):990-1000. doi: 10.1093/infdis/jiz225.

PMID:
31058977
2.

Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers.

Lal M, Jarrahian C, Zhu C, Hosken NA, McClurkan CL, Koelle DM, Saxon E, Roehrig A, Zehrung D, Chen D.

Vaccine. 2016 May 11;34(22):2483-9. doi: 10.1016/j.vaccine.2016.03.093. Epub 2016 Apr 13.

PMID:
27085171
3.

Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.

White JA, Blum JS, Hosken NA, Marshak JO, Duncan L, Zhu C, Norton EB, Clements JD, Koelle DM, Chen D, Weldon WC, Oberste MS, Lal M.

Hum Vaccin Immunother. 2014;10(12):3611-21. doi: 10.4161/hv.32253.

4.

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ.

J Exp Med. 2005 Sep 5;202(5):673-85.

5.

Development of a therapeutic vaccine for HSV-2.

Hosken NA.

Vaccine. 2005 Mar 18;23(17-18):2395-8.

PMID:
15755634
6.

Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Koelle DM, Liu Z, McClurkan CL, Cevallos RC, Vieira J, Hosken NA, Meseda CA, Snow DC, Wald A, Corey L.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12899-904. Epub 2003 Oct 17.

7.

The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.

Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A.

J Exp Med. 1995 Nov 1;182(5):1579-84.

8.

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.

Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, O'Garra A.

J Exp Med. 1995 Nov 1;182(5):1357-67.

9.

Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.

Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A.

J Immunol. 1995 May 15;154(10):5071-9.

PMID:
7730613
10.
11.

Defective presentation of endogenous antigen by a cell line expressing class I molecules.

Hosken NA, Bevan MJ.

Science. 1990 Apr 20;248(4953):367-70.

PMID:
2326647
12.

Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.

Hosken NA, Bevan MJ, Carbone FR.

J Immunol. 1989 Feb 15;142(4):1079-83.

PMID:
2492575
13.

Class I MHC-restricted cytotoxic responses to soluble protein antigen.

Carbone FR, Hosken NA, Moore MW, Bevan MJ.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:551-5. Review. No abstract available.

PMID:
2700945

Supplemental Content

Loading ...
Support Center